DJIA 17,013.10 -26.39 -0.15%
NASDAQ 4,543.42 11.32 0.25%
S&P 500 1,989.82 -2.55 -0.13%
market minute promo

0.00 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IDIX 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -0.97





Idenix Pharmaceuticals, Inc. (IDIX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe. Website:

News & Commentary

Biotech M&A: Do We Need a New Driver?

Hepatitis C acquisitions like we've seen from Gilead, Bristol-Myers Squibb, and Merck can't last forever.

Prem Watsa Buys 4 New Stocks

Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential

Merck: Should You Buy It?

Gilead: A Growth Story

Ukraine Tension Prominent As Dow Suffers Triple Point Digit Loss; S&P 500 & Nasdaq Also Lower

Outstanding Performance Award Winners

Merck, J&J, Baxter Provide Healthy Dividend Stream

Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog

Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog

Today In SA PRO: Monday, July 28

Announcing SA's First Outstanding Performance Award Winners

See More IDIX News...

IDIX's Top Competitors

IDIX 0.00 (0.00%)
Current stock: IDIX
AMGN $133.06 (0.40%)
Current stock: AMGN
CELG $91.75 (0.10%)
Current stock: CELG
BIIB $340.61 (0.58%)
Current stock: BIIB